NanoCell Therapeutics, Inc.
Non-viral DNA-based in vivo gene therapy platform, transforming adoptive cell therapy into in vivo gene therapy. We primarily develop in vivo CAR-TCR therapies, using proprietary cell-directed lipid nanoparticles for delivery of stably integrating DNA, to provide durable efficacy.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}